Express Pharma - Express Pharma

Lupin has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug…

Sekhar Surabhi, CEO & Founder, Caliber Technologies and Director, ISPE India Affiliate, Chair, ISPE Pharma 4.0, Community of…

Saroj G. Warke, Co-founder and IT Director of HiMedia Laboratories has received the prestigious “Women Empowerment Principles…

The inaugural edition of the Peptides & Complex Generics Symposium (PCG 2025), jointly organised by the Mumbai Biocluster and…

The Central Drugs Standard Control Organization (CDSCO) has issued a clarification concerning the regulatory approval process for…

With semaglutide patents set to expire in 2026, Indian drugmakers are preparing to enter the market with generics. This…

The Ministry of Ayush inaugurated the Integrative Oncology Research and Care Centre (IORCC) at the All India Institute of Ayurveda…

Lupin’s wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acquisition of VISUfarma B.V.…

US President Trump's fresh salvo of 100 per cent tariffs on branded or patented pharmaceutical products not ‘Made in America’…

Chakravarthi AVPS, International Trade & Business Relations Expert in pharmaceuticals, opines that for India Pharma Inc, the…